Neos könnte eine Neubewertung anstehen, die Scriptzahlen für Q4 sehen gut auch ca. 8 Prozent höher als bei Q3 bei Adzenys X-ODT and Cotempla XR-ODT zusammengenommen. Vielleicht konnten Sie auch höhere Preise erzielen, und es währe wohl der Breakeven erreicht.
Well here are the script numbers for Q4 (October, November December) For me numbers in Adzenys X-ODT and Cotempla XR-ODT are just good with a slight increase compare to numbers for Q3-
But what is HUGE!!! is what is happening with Tussionex, something there is different and I am expecting something similar to happen on A and C when their season comes. I am sure Jerry will have to mention something regarding Tussionex, because such increase for me has to be that the big chain of pharmacies is in place and the season for that product has created the perfect set up, And if this is the case, then I am sure Jerry will mention something that he expects to see similar growth on A and C when peak season comes. Look at the numbers , Look at Tussionex for December!!!
Adzenys X-ODT Total Scripts by Month
October.... 21.150 November....19.200 December......19.350 Total...............59.700 UP from 56.280 on Q3
Cotempla XR-ODT Total Scripts by Month
October.... 14.870 November....13.500 December......13.730 Total...............42.100 UP from 37.740 on Q3
The Beast Mode Tussionex Scripts by Month
October.... 23.390 November....28.910 December......41.690 !!!!!!!!!!!!!! HUGE Total ..........93.990 UP BIG from 44.110
More than 100% increase on Tussionex!!! from last Q. The day we see something like that in A and C, then watch out. And God willing I shall live and I believe that day is coming!!!! very soon.
Looking forward to Q4 report and Jerry´s explanation of what is going on with Lynch Tussionex!!! LOL!!!
|